| Revenues | | 9,177.00 | 7,197.00 | 7,091.00 | 7,727.00 |
| Cost Of Revenue | | 7,139.00 | 6,496.00 | 6,756.00 | 6,821.00 |
| | 387.00 | 411.00 | - | - |
| Selling, General, and Administrative | | 387.00 | 411.00 | - | - |
| Research and Development | | 34.00 | 36.00 | - | - |
| Costs And Expenses | | 7,634.00 | 6,958.00 | 7,179.00 | 8,458.00 |
| Operating Income/Loss | | 1,543.00 | 239.00 | -88.00 | -731.00 |
| Income/Loss From Equity Method Investments | | 57.00 | -5.00 | -12.00 | -8.00 |
| Income/Loss From Continuing Operations Before Tax | | 808.00 | 137.00 | -142.00 | -856.00 |
| Income Tax Expense/Benefit | | 236.00 | -2.00 | -8.00 | -27.00 |
| Income/Loss From Continuing Operations After Tax | | 572.00 | 139.00 | -134.00 | -829.00 |
| Income/Loss From Discontinued Operations, Net Of Tax | | -13.00 | -14.00 | -6.00 | -61.00 |
| Net Income/Loss | | 559.00 | 125.00 | -140.00 | -890.00 |
| Basic Earnings Per Share | | 1.71 | 0.38 | -0.45 | -2.77 |
| Diluted Earnings Per Share | | 1.71 | 0.38 | -0.45 | -2.77 |
| Common Stock Dividends | 0.69 | 0.69 | 0.69 | 1.37 | 1.37 |
